The physiopathological role of IL-33: New highlights in bone biology and a proposed role in periodontal disease

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Cordero Da Luz, Felipe Andrés ^a   Lima Oliveira, Ana Paula ^a   Borges, Daniella ^a   Cristina Brígido, Paula ^a   Silva, Marcelo José Barbosa ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BONE MORPHOGENETIC PROTEIN; COLONY STIMULATING FACTOR 1; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 4; ONCOSTATIN M; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTHRITIS; BONE DESTRUCTION; BONE EROSION; BONE REMODELING; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CELL FATE; CELL TYPE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTERSTITIAL LUNG DISEASE; MARKER GENE; MAST CELL DEGRANULATION; MICROENVIRONMENT; MONOCYTE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOLYSIS; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 84896257877     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/342410     Document Type: Review

References (47)

1. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T. K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D. M., Bazan J. F., Kastelein R. A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005 23 5 479 490 2-s2.0-27744446058 10.1016/j.immuni.2005.09.015 (Pubitemid 41587888)
2. Joshi A. D., Oak S. R., Hartigan A. J., Finn W. G., Kunkel S. L., Duffy K. E., Das A., Hogaboam C. M., Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. BMC Immunology 2010 11, article no. 52 2-s2.0-77957910133 10.1186/1471-2172-11-52
3. Tominaga S.-I., Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Komatsu N., Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochemical and Biophysical Research Communications 1999 264 1 14 18 2-s2.0-0033554599 10.1006/bbrc.1999.1469 (Pubitemid 29500455)
4. Hayakawa H., Hayakawa M., Kume A., Tominaga S.-I., Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. Journal of Biological Chemistry 2007 282 36 26369 26380 2-s2.0-34548825396 10.1074/jbc.M704916200 (Pubitemid 47443815)
5. Cayrol C., Girard J.-P., The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences of the United States of America 2009 106 22 9021 9026 2-s2.0-67049158193 10.1073/pnas.0812690106
6. Lefrançais E., Roga S., Gautier V., Gonzalez-de-Peredo A., Monsarrat B., Girard J.-P., Cayrol C., IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proceedings of the National Academy of Sciences of the United States of America 2012 109 5 1673 1678 2-s2.0-84857134135 10.1073/pnas.1115884109
7. Nile C. J., Barksby E., Jitprasertwong P., Preshaw P. M., Taylor J. J., Expression and regulation of interleukin-33 in human monocytes. Immunology 2010 130 2 172 180 2-s2.0-77952087293 10.1111/j.1365-2567.2009.03221.x
8. Haraldsen G., Balogh J., Pollheimer J., Sponheim J., Küchler A. M., Interleukin-33-cytokine of dual function or novel alarmin? Trends in Immunology 2009 30 5 227 233 2-s2.0-65149097030 10.1016/j.it.2009.03.003
9. Roussel L., Erard M., Cayrol C., Girard J.-P., Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Reports 2008 9 10 1006 1012 2-s2.0-53249093714 10.1038/embor.2008.145
10. Rank M. A., Kobayashi T., Kozaki H., Bartemes K. R., Squillace D. L., Kita H., IL-33-activated dendritic cells induce an atypical TH2-type response. Journal of Allergy and Clinical Immunology 2009 123 5 1047 1054 2-s2.0-67349084096 10.1016/j.jaci.2009.02.026
11. Komai-Koma M., Xu D., Li Y., McKenzie A. N. J., McInnes I. B., Liew F. Y., IL-33 is a chemoattractant for human Th2 cells. European Journal of Immunology 2007 37 10 2779 2786 2-s2.0-35348850153 10.1002/eji.200737547 (Pubitemid 47578297)
12. Cherry W. B., Yoon J., Bartemes K. R., Iijima K., Kita H., A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. The Journal of Allergy and Clinical Immunology 2008 121 6 1484 1490 2-s2.0-44649129170 10.1016/j.jaci.2008.04.005 (Pubitemid 351787349)
13. Pecaric-Petkovic T., Didichenko S. A., Kaempfer S., Spiegl N., Dahinden C. A., Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009 113 7 1526 1534 2-s2.0-61849117309 10.1182/blood-2008-05-157818
14. Smithgall M. D., Comeau M. R., Park Yoon B.-R., Kaufman D., Armitage R., Smith D. E., IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th 2 cells, iNKT and NK Cells. International Immunology 2008 20 8 1019 1030 2-s2.0-48449089903 10.1093/intimm/dxn060
15. Alves-Filho J. C., Snego F., Souto F. O., Freitas A., Verri W. A. Jr., Auxiliadora-Martins M., Basile-Filho A., McKenzie A. N., Xu D., Cunha F. Q., Liew F. Y., Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nature Medicine 2010 16 6 708 712 2-s2.0-77953185426 10.1038/nm.2156
16. Kurowska-Stolarska M., Stolarski B., Kewin P., Murphy G., Corrigan C. J., Ying S., Pitman N., Mirchandani A., Rana B., Van Rooijen N., Shepherd M., McSharry C., McInnes I. B., Xu D., Liew F. Y., IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. Journal of Immunology 2009 183 10 6469 6477 2-s2.0-75549085516 10.4049/jimmunol.0901575
17. Chackerian A. A., Oldham E. R., Murphy E. E., Schmitz J., Pflanz S., Kastelein R. A., IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. Journal of Immunology 2007 179 4 2551 2555 2-s2.0-34848899012
18. Palmer G., Talabot-Ayer D., Lamacchia C., Toy D., Seemayer C. A., Viatte S., Finckh A., Smith D. E., Gabay C., Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis and Rheumatism 2009 60 3 738 749 2-s2.0-61649117392 10.1002/art.24305
19. Pushparaj P. N., Hwee K. T., Shiau C. H., Pitman N., Xu D., McKenzie A., Liew F. Y., Melendez A. J., The cytokine interleukin-33 mediates anaphylactic shock. Proceedings of the National Academy of Sciences of the United States of America 2009 106 24 9773 9778 2-s2.0-67649852593 10.1073/pnas.0901206106
20. Allakhverdi Z., Smith D. E., Comeau M. R., Delespesse G., Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. Journal of Immunology 2007 179 4 2051 2054 2-s2.0-34848886843
21. Moulin D., Donzé O., Talabot-Ayer D., Mézin F., Palmer G., Gabay C., Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007 40 3 216 225 2-s2.0-36749026651 10.1016/j.cyto.2007.09.013 (Pubitemid 350213434)
22. Komai-Koma M., Brombacher F., Pushparaj P. N., Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 2012 67 9 1118 1126
23. Kropf P., Herath S., Klemenz R., Müller I., Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection. Infection and Immunity 2003 71 4 1961 1971 2-s2.0-0037378857 10.1128/IAI.71.4.1961-1971.2003 (Pubitemid 36368729)
24. Jones L. A., Roberts F., Nickdel M. B., Brombacher F., McKenzie A. N. J., Henriquez F. L., Alexander J., Roberts C. W., IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. European Journal of Immunology 2010 40 2 426 436 2-s2.0-75149148187 10.1002/eji.200939705
25. Humphreys N. E., Xu D., Hepworth M. R., Liew F. Y., Grencis R. K., IL-33, a potent inducer of adaptive immunity to intestinal nematodes. Journal of Immunology 2008 180 4 2443 2449 2-s2.0-42149179961
26. Dinarello C. A., An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 2005 23 5 461 462 2-s2.0-27744438007 10.1016/j.immuni.2005.10.004 (Pubitemid 41587885)
27. Hong Y.-S., Moon S.-J., Joo Y.-B., Jeon C.-H., Cho M.-L., Ju J. H., Oh H.-J., Heo Y.-J., Park S.-H., Kim H.-Y., Min J.-K., Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. Journal of Korean Medical Science 2011 26 9 1132 1139 2-s2.0-80052818476 10.3346/jkms.2011.26.9.1132
28. Xu D., Jiang H.-R., Kewin P., Li Y., Mu R., Fraser A. R., Pitman N., Kurowska-Stolarska M., McKenzie A. N. J., McInnes I. B., Liew F. Y., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10913 10918 2-s2.0-49449111630 10.1073/pnas.0801898105
29. Zaiss M. M., Kurowska-Stolarska M., Böhm C., Gary R., Scholtysek C., Stolarski B., Reilly J., Kerr S., Millar N. L., Kamradt T., McInnes I. B., Fallon P. G., David J.-P., Liew F. Y., Schett G., IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-mediated bone loss. Journal of Immunology 2011 186 11 6097 6105 2-s2.0-79958073057 10.4049/jimmunol.1003487
30. Xiangyang Z., Lutian Y., Lin Z., Liping X., Hui S., Jing L., Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 2012 58 1 6 9 2-s2.0-84857447895 10.1016/j.cyto.2011.12.010
31. Andersen T. L., Sondergaard T. E., Skorzynska K. E., Dagnaes-Hansen F., Plesner T. L., Hauge E. M., Plesner T., Delaisse J.-M., A physical mechanism for coupling bone resorption and formation in adult human bone. American Journal of Pathology 2009 174 1 239 247 2-s2.0-58249109354 10.2353/ajpath.2009.080627
32. Walkley C. R., Shea J. M., Sims N. A., Purton L. E., Orkin S. H., Rb Regulates Interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007 129 6 1081 1095 2-s2.0-34250363611 10.1016/j.cell.2007.03.055 (Pubitemid 46908695)
33. Gillespie M. T., Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Research and Therapy 2007 9 2, article 103 2-s2.0-36048959240 10.1186/ar2141
34. Horowitz M. C., Lorenzo J. A., B lymphocytes and the skeleton. Annals of the New York Academy of Sciences 2007 1117 82 93 2-s2.0-36549015195 10.1196/annals.1402.045 (Pubitemid 350191280)
35. Elefteriou F., Regulation of bone remodeling by the central and peripheral nervous system. Archives of Biochemistry and Biophysics 2008 473 2 231 236 2-s2.0-50949118377 10.1016/j.abb.2008.03.016
36. Papachristou D. J., Basdra E. K., Papavassiliou A. G., Bone metastases: molecular mechanisms and novel therapeutic interventions. Medicinal Research Reviews 2012 32 3 611 636 2-s2.0-84860325176 10.1002/med.20224
37. Dougall W. C., Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clinical Cancer Research 2012 18 2 326 335 2-s2.0-84855999380 10.1158/1078-0432.CCR-10-2507
38. Kong Y.-Y., Yoshida H., Sarosi I., Tan H.-L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A. J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C. R., Lacey D. L., Mak T. W., Boyle W. J., Penninger J. M., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999 397 6717 315 323 2-s2.0-0033611467 10.1038/16852 (Pubitemid 29061638)
39. Mun S. H., Ko N. Y., Kim H. S., Kim J. W., Kim D. K., Kim A.-R., Lee S. H., Kim Y.-G., Lee C. K., Lee S. H., Kim B. K., Beaven M. A., Kim Y. M., Choi W. S., Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes. Cellular and Molecular Life Sciences 2010 67 22 3883 3892 2-s2.0-78149470328 10.1007/s00018-010-0410-y
40. Saidi S., Bouri F., Lencel P., Duplomb L., Baud'huin M., Delplace S., Leterme D., Miellot F., Heymann D., Hardouin P., Palmer G., Magne D., IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine 2011 53 3 347 354 2-s2.0-79251608793 10.1016/j.cyto.2010.11.021
41. Saleh H., Eeles D., Hodge J. M., Nicholson G. C., Gu R., Pompolo S., Gillespie M. T., Quinn J. M. W., Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology 2011 152 5 1911 1922 2-s2.0-79955374217 10.1210/en.2010-1268
42. Schulze J., Bickert T., Beil F. T., Zaiss M. M., Albers J., Wintges K., Streichert T., Klaetschke K., Keller J., Hissnauer T.-N., Spiro A. S., Gessner A., Schett G., Amling M., McKenzie A. N. J., Horst A. K., Schinke T., Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. Journal of Bone and Mineral Research 2011 26 4 704 717 2-s2.0-79953065064 10.1002/jbmr.269
43. Keller J., Catala-Lehnen P., Wintges K., Schulze J., Bickert T., Ito W., Horst A. K., Amling M., Schinke T., Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis. Biochemical and Biophysical Research Communications 2012 417 1 217 222 2-s2.0-84855795870 10.1016/j.bbrc.2011.11.088
44. Geissmann F., Manz M. G., Jung S., Sieweke M. H., Merad M., Ley K., Development of monocytes, macrophages, and dendritic cells. Science 2010 327 5966 656 661 2-s2.0-76249095169 10.1126/science.1178331
45. Kayal R. A., The role of osteoimmunology in periodontal disease. BioMed Research International 2013 2013 12 639368 10.1155/2013/639368
46. Lagdive S. S., Lagdive S. B., Mani A., Anarthe R., Correlation of mast cells in periodontal diseases. Journal of Indian Society of Periodontology 2013 17 1 63 67
47. Huang S., Lu F., Chen Y., Huang B., Liu M., Mast cell degranulation in human periodontitis. Journal of Periodontology 2013 84 2 248 255